Investor Presentaiton

2021 FINANCIAL GUIDANCE Sales ● Breast Products net sales of $72 - $76 million, representing 31 - 38% y/y growth Operating Expenses • FY 2021 OpEx expected to be in the range of $85 - $90 million(1) sientra. 1 Excluding impairment and restructuring charges 16

View entire presentation